Comments
Loading...
Scotts Miracle Gro Analyst Ratings and Price Targets | NYSE:SMG | Benzinga
The Scotts Miracle Gro Co has a consensus price target of $72 based on the ratings of 8 analysts. The high is $80 issued by Wells Fargo on January 7, 2025. The low is $60 issued by Barclays on September 5, 2023. The 3 most-recent analyst ratings were released by Stifel, UBS, and Wells Fargo on March 4, 2025, January 16, 2025, and January 7, 2025, respectively. With an average price target of $74 between Stifel, UBS, and Wells Fargo, there's an implied 30.44% upside for The Scotts Miracle Gro Co from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stifel
UBS
Wells Fargo
Jefferies
Truist Securities
1calculated from analyst ratings
Analyst Ratings for Scotts Miracle Gro
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/04/2025 | Buy Now | 23.39% | Stifel | W. Andrew Carter41% | $78 → $70 | Upgrade | Hold → Buy | Get Alert |
| 01/16/2025 | Buy Now | 26.92% | UBS | Peter Grom54% | $77 → $72 | Maintains | Neutral | Get Alert |
| 01/07/2025 | Buy Now | 41.02% | Wells Fargo | Chris Carey62% | $85 → $80 | Maintains | Overweight | Get Alert |
| 12/09/2024 | Buy Now | 26.92% | Jefferies | Jonathan Matuszewski54% | → $72 | Initiates | → Hold | Get Alert |
| 11/08/2024 | Buy Now | 23.39% | Truist Securities | Bill Chappell46% | $90 → $70 | Maintains | Hold | Get Alert |
| 11/07/2024 | Buy Now | 41.02% | JP Morgan | Jeffrey Zekauskas67% | $85 → $80 | Maintains | Overweight | Get Alert |
| 11/07/2024 | Buy Now | 35.73% | UBS | Peter Grom54% | $90 → $77 | Maintains | Neutral | Get Alert |
| 11/07/2024 | Buy Now | 49.83% | Wells Fargo | Chris Carey62% | $95 → $85 | Maintains | Overweight | Get Alert |
| 11/04/2024 | Buy Now | 42.78% | Stifel | W. Andrew Carter41% | $75 → $81 | Maintains | Hold | Get Alert |
| 10/16/2024 | Buy Now | 58.65% | Truist Securities | Bill Chappell46% | $65 → $90 | Maintains | Hold | Get Alert |
| 08/02/2024 | Buy Now | 32.21% | Stifel | W. Andrew Carter41% | $70 → $75 | Maintains | Hold | Get Alert |
| 08/01/2024 | Buy Now | 49.83% | Wells Fargo | Chris Carey62% | $75 → $85 | Maintains | Overweight | Get Alert |
| 07/10/2024 | Buy Now | 32.21% | Wells Fargo | Chris Carey62% | $83 → $75 | Maintains | Overweight | Get Alert |
| 05/02/2024 | Buy Now | 46.31% | Wells Fargo | Chris Carey62% | $85 → $83 | Maintains | Overweight | Get Alert |
| 04/05/2024 | Buy Now | 32.21% | Truist Securities | Bill Chappell46% | $65 → $75 | Downgrade | Buy → Hold | Get Alert |
| 04/05/2024 | Buy Now | 49.83% | JP Morgan | Jeffrey Zekauskas67% | $70 → $85 | Maintains | Overweight | Get Alert |
| 03/25/2024 | Buy Now | — | Raymond James | Joseph Altobello69% | — | Downgrade | Strong Buy → Market Perform | Get Alert |
| 03/04/2024 | Buy Now | 14.58% | Stifel | W. Andrew Carter41% | $55 → $65 | Maintains | Hold | Get Alert |
| 02/05/2024 | Buy Now | -3.05% | Stifel | W. Andrew Carter41% | $49 → $45 | Maintains | Hold | Get Alert |
| 10/30/2023 | Buy Now | -13.63% | Stifel | W. Andrew Carter41% | $55 → $49 | Maintains | Hold | Get Alert |
| 09/05/2023 | Buy Now | 5.76% | Barclays | Gaurav Jain63% | $70 → $60 | Maintains | Equal-Weight | Get Alert |
| 08/07/2023 | Buy Now | -3.05% | Stifel | W. Andrew Carter41% | $68 → $55 | Maintains | Hold | Get Alert |
| 08/03/2023 | Buy Now | 23.39% | Raymond James | Joseph Altobello69% | $86 → $70 | Maintains | Strong Buy | Get Alert |
| 08/03/2023 | Buy Now | 32.21% | Truist Securities | Bill Chappell46% | $80 → $75 | Maintains | Buy | Get Alert |
| 08/01/2023 | Buy Now | 19.87% | Stifel | W. Andrew Carter41% | $72 → $68 | Maintains | Hold | Get Alert |
| 07/13/2023 | Buy Now | 26.92% | Stifel | W. Andrew Carter41% | $78 → $72 | Downgrade | Buy → Hold | Get Alert |
| 07/11/2023 | Buy Now | — | Truist Securities | Bill Chappell46% | — | Upgrade | Hold → Buy | Get Alert |
| 05/08/2023 | Buy Now | 41.02% | JP Morgan | Jeffrey Zekauskas67% | → $80 | Upgrade | Neutral → Overweight | Get Alert |
| 05/04/2023 | Buy Now | 14.58% | Truist Securities | Bill Chappell46% | $70 → $65 | Maintains | Hold | Get Alert |
| 05/04/2023 | Buy Now | 49.83% | Wells Fargo | Chris Carey62% | $100 → $85 | Maintains | Overweight | Get Alert |
| 05/01/2023 | Buy Now | 41.02% | Stifel | W. Andrew Carter41% | $65 → $80 | Upgrade | Hold → Buy | Get Alert |
| 04/26/2023 | Buy Now | 23.39% | Barclays | Gaurav Jain63% | $105 → $70 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 04/06/2023 | Buy Now | 41.02% | UBS | Peter Grom54% | $87 → $80 | Maintains | Neutral | Get Alert |
| 02/21/2023 | Buy Now | 85.09% | Barclays | Gaurav Jain63% | $90 → $105 | Maintains | Overweight | Get Alert |
| 02/16/2023 | Buy Now | 76.27% | Wells Fargo | Chris Carey62% | $75 → $100 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 02/02/2023 | Buy Now | 23.39% | Truist Securities | Bill Chappell46% | $50 → $70 | Maintains | Hold | Get Alert |
| 02/02/2023 | Buy Now | 41.02% | JP Morgan | Jeffrey Zekauskas67% | $45 → $80 | Maintains | Neutral | Get Alert |
| 02/02/2023 | Buy Now | 32.21% | Wells Fargo | Chris Carey62% | $60 → $75 | Maintains | Equal-Weight | Get Alert |
| 02/02/2023 | Buy Now | 62.17% | Raymond James | Joseph Altobello69% | $56 → $92 | Maintains | Strong Buy | Get Alert |
| 01/31/2023 | Buy Now | 5.76% | Wells Fargo | Chris Carey62% | $50 → $60 | Maintains | Equal-Weight | Get Alert |
| 01/31/2023 | Buy Now | 58.65% | Barclays | Gaurav Jain63% | $75 → $90 | Maintains | Overweight | Get Alert |
| 11/08/2022 | Buy Now | 32.21% | Barclays | Gaurav Jain63% | → $75 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 11/03/2022 | Buy Now | -20.68% | JP Morgan | Jeffrey Zekauskas67% | $80 → $45 | Maintains | Neutral | Get Alert |
| 11/03/2022 | Buy Now | -1.29% | Raymond James | Joseph Altobello69% | $100 → $56 | Maintains | Strong Buy | Get Alert |
| 10/03/2022 | Buy Now | -11.86% | Wells Fargo | Chris Carey62% | $75 → $50 | Maintains | Equal-Weight | Get Alert |
| 09/01/2022 | Buy Now | 32.21% | Wells Fargo | Chris Carey62% | $85 → $75 | Maintains | Equal-Weight | Get Alert |
| 08/04/2022 | Buy Now | 51.6% | UBS | Peter Grom54% | $92 → $86 | Maintains | Neutral | Get Alert |
| 08/04/2022 | Buy Now | 76.27% | Raymond James | Joseph Altobello69% | $110 → $100 | Maintains | Strong Buy | Get Alert |
| 07/22/2022 | Buy Now | 62.17% | UBS | Peter Grom54% | $125 → $92 | Downgrade | Buy → Neutral | Get Alert |
| 06/22/2022 | Buy Now | 49.83% | Wells Fargo | Chris Carey62% | → $85 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 06/14/2022 | Buy Now | 63.93% | Stifel | W. Andrew Carter41% | $116 → $93 | Maintains | Hold | Get Alert |
| 06/09/2022 | Buy Now | 102.71% | Wells Fargo | Chris Carey62% | $130 → $115 | Maintains | Overweight | Get Alert |
| 06/09/2022 | Buy Now | 67.46% | JP Morgan | Jeffrey Zekauskas67% | → $95 | Downgrade | Overweight → Neutral | Get Alert |
| 06/09/2022 | Buy Now | 93.9% | Raymond James | Joseph Altobello69% | $125 → $110 | Maintains | Strong Buy | Get Alert |
| 06/08/2022 | Buy Now | 49.83% | Truist Securities | Bill Chappell46% | $185 → $85 | Downgrade | Buy → Hold | Get Alert |
| 06/02/2022 | Buy Now | 129.16% | Wells Fargo | Chris Carey62% | $145 → $130 | Maintains | Overweight | Get Alert |
| 05/04/2022 | Buy Now | 120.34% | Raymond James | Joseph Altobello69% | $150 → $125 | Maintains | Strong Buy | Get Alert |
| 05/04/2022 | Buy Now | 155.6% | Wells Fargo | Chris Carey62% | $155 → $145 | Maintains | Overweight | Get Alert |
| 05/04/2022 | Buy Now | 129.16% | JP Morgan | Jeffrey Zekauskas67% | → $130 | Upgrade | Neutral → Overweight | Get Alert |
| 05/04/2022 | Buy Now | 104.48% | Stifel | W. Andrew Carter41% | $130 → $116 | Downgrade | Buy → Hold | Get Alert |
| 04/21/2022 | Buy Now | 93.9% | Barclays | Gaurav Jain63% | $150 → $110 | Downgrade | Overweight → Equal-Weight | Get Alert |
FAQ
What is the target price for Scotts Miracle Gro (SMG) stock?
The latest price target for Scotts Miracle Gro (NYSE:SMG) was reported by Stifel on March 4, 2025. The analyst firm set a price target for $70.00 expecting SMG to rise to within 12 months (a possible 23.39% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Scotts Miracle Gro (SMG)?
The latest analyst rating for Scotts Miracle Gro (NYSE:SMG) was provided by Stifel, and Scotts Miracle Gro upgraded their buy rating.
When was the last upgrade for Scotts Miracle Gro (SMG)?
The last upgrade for The Scotts Miracle Gro Co happened on March 4, 2025 when Stifel raised their price target to $70. Stifel previously had a hold for The Scotts Miracle Gro Co.
When was the last downgrade for Scotts Miracle Gro (SMG)?
The last downgrade for The Scotts Miracle Gro Co happened on April 5, 2024 when Truist Securities changed their price target from $65 to $75 for The Scotts Miracle Gro Co.
When is the next analyst rating going to be posted or updated for Scotts Miracle Gro (SMG)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Scotts Miracle Gro, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Scotts Miracle Gro was filed on March 4, 2025 so you should expect the next rating to be made available sometime around March 4, 2026.
Is the Analyst Rating Scotts Miracle Gro (SMG) correct?
While ratings are subjective and will change, the latest Scotts Miracle Gro (SMG) rating was a upgraded with a price target of $78.00 to $70.00. The current price Scotts Miracle Gro (SMG) is trading at is $56.73, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.